Variants in the GPR146 Gene Are Associated With a Favorable Cardiometabolic Risk Profile.
Antoine RimbertMing Wai YeungNawar DalilaChris H L ThioHaojie YuNatalia LoaizaFederico OldoniAdriaan van der GraafSiqi WangM Abdullah SaidLisanne L BlauwAurore GirardeauLise BrayAmandine CaillaudVincent W BloksMarie MarrecPhilippe MoulinPatrick C N RensenBart van de SluisHarold SniederMathilde Di FilippoPim van der HarstAnne Tybjaerg-HansenPhilip ZimmermanBertrand CariouJan Albert KuivenhovenPublished in: Arteriosclerosis, thrombosis, and vascular biology (2022)
variants have a beneficial cardiometabolic risk profile, but it remains to be shown whether genetic or pharmaceutical inhibition of GPR146 protects against atherosclerosis in humans.